S. Korea FDA Warns Against Cold Medicines For Children Under 2
This article was originally published in PharmAsia News
Korea's Food and Drug Administration warned physicians and the public against giving over-the-counter cold medicines to children under two years old. The warning also said giving children two kinds of antihistamine cold pills at the same time could be fatal. The agency stopped short of banning fever medicines such as ibuprofen and acetaminophen, but urged drug makers to put warnings on their labels to provide notice of the dangers of not following recommended dosages for children under two. (Click here for more
You may also be interested in...
Chugai is pursuing further Japanese litigation over generic rivals to its Edirol brand, this time concerning the eldecalcitol ingredient produced by Nissan Chemical.
The European Commission has unexpectedly concluded that CBD should not be considered as a drug opening up the path to a regulated EU market for the cannabinoid as a novel food.
As Apotex names its new US president and CEO, Akorn puts together a fresh board of directors following bankruptcy proceedings. Stada has made new appointments in Germany, while Siegfried makes significant changes in its leadership roles.